Arteris, Inc. (NASDAQ:AIP) has disclosed a substantial insider stock transaction involving its President and Chief Executive Officer, Janac K. Charles. On July 6, 2026, Mr. Janac executed the sale of 136,655 shares of the company's common stock. The aggregate value of this divestment reached approximately $4.89 million. The shares were sold at varying prices within a range of $35.065 to $37.1178 per share.
The timing of this transaction is particularly noteworthy given the recent performance of Arteris's stock. Over the past week leading up to the sale, the stock price declined by 28.5%. Despite this short-term volatility, the stock has demonstrated significant long-term growth, remaining up 228% over the past year. According to analysis provided by InvestingPro, Arteris currently appears overvalued relative to its Fair Value. This assessment places Arteris among the most overvalued stocks tracked by the platform. Investors seeking deeper insights can access a comprehensive Pro Research Report on Arteris, one of 1,400+ US equities covered by the service.
These transactions were conducted pursuant to a pre-arranged 10b5-1 trading plan, which Mr. Janac adopted on December 12, 2025. This structure is designed to facilitate the execution of stock sales in a manner that complies with insider trading regulations.
Mr. Janac directly disposed of 10,679 shares of common stock. These direct sales were executed in multiple transactions, with weighted average prices of $35.1155 (for 5,316 shares sold between $34.67 and $35.55), $36.169 (for 2,455 shares sold between $35.69 and $36.67), and $37.1178 (for 2,908 shares sold between $36.77 and $37.57).
Additionally, 125,976 shares were sold indirectly through Bayview Legacy, LLC, an entity for which Mr. Janac serves as manager and is deemed to have voting and dispositive power. These indirect sales also occurred in multiple transactions, with weighted average prices of $37.0705 (for 29,490 shares sold between $36.66 and $37.58), $36.2365 (for 27,908 shares sold between $35.66 and $36.655), and $35.065 (for 68,578 shares sold between $34.64 and $35.63).
Following these transactions, Mr. Janac directly holds 175,148 shares of Arteris common stock. Indirectly, Bayview Legacy, LLC holds 8,429,071 shares, and the Charles and Lydia Janac Trust, for which Mr. Janac is trustee, holds 56,252 shares.
In other recent news, Arteris Inc. has reported several significant developments. The company has partnered with IC-Link by imec to deploy its network-on-chip intellectual property for AI and high-performance computing chiplets and application-specific integrated circuits. This collaboration aims to integrate Arteris NoC IP technology with IC-Link's expertise to offer reusable architecture for custom semiconductor platforms. Additionally, SiEngine Technology has licensed Arteris' FlexNoC network-on-chip interconnect IP for its next-generation automotive system-on-chip platform, focusing on intelligent cockpit and advanced driver assistance applications.
In the automotive sector, Li Auto Inc. has deployed Arteris' system IP technology in its L9 Livis SUV and plans to incorporate it into future vehicles. The technology used includes Arteris FlexNoC 5 NoC interconnect IP and Magillem SoC integration automation software, which supports AI computational tasks. On the financial side, TD Cowen has raised its price target for Arteris shares to $40 from $22, maintaining a Buy rating. This decision follows Arteris' first-quarter performance and raised guidance for the second quarter and full year 2026, with all metrics surpassing expectations. Meanwhile, Northland maintains a market perform rating on Intel Corp., noting that Intel's recent developments show progress in catching up with competitors in process technology.